| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.119 | 2.167 | 4.154 | 14.022 | 10.973 | 9.237 |
| Total Income - EUR | - | - | - | - | 3.119 | 2.167 | 4.154 | 14.022 | 10.973 | 9.237 |
| Total Expenses - EUR | - | - | - | - | 1.481 | 237 | 1.741 | 3.843 | 8.770 | 7.331 |
| Gross Profit/Loss - EUR | - | - | - | - | 1.638 | 1.930 | 2.413 | 10.179 | 2.203 | 1.906 |
| Net Profit/Loss - EUR | - | - | - | - | 1.544 | 1.865 | 2.288 | 9.758 | 953 | 1.534 |
| Employees | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anestidoc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 106 | 104 | 102 | 736 | 463 | 191 |
| Current Assets | - | - | - | - | 7.648 | 9.433 | 11.436 | 9.370 | 2.835 | 3.326 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 287 |
| Receivables | - | - | - | - | 137 | 83 | 243 | 618 | 300 | 585 |
| Cash | - | - | - | - | 7.511 | 9.350 | 11.193 | 8.752 | 2.535 | 2.454 |
| Shareholders Funds | - | - | - | - | 7.497 | 9.220 | 11.304 | 9.807 | 1.001 | 2.529 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 257 | 317 | 234 | 300 | 2.297 | 988 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anestidoc Srl